• Profile
Close

Reduce Covishield dose gap to 8-16 weeks, recommends panel

IANS Mar 21, 2022

The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between the first and second dose of COVID vaccine Covishield to 8 to 16 weeks in view of the ongoing Omicron pandemic, said a source on March 20.


Presently, the second dose of Covishield is being administered 12-16 weeks after the first dose under the national vaccination drive. India's apex body on immunisation now recommends this be curbed to ramp up the administration of the second dose of Covishield to the remaining population amid rising cases in European nations and some other countries.

The government had on May 13, 2021, extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks, based on the recommendations by NTAGI that provides guidance to the Union Health Ministry on the immunisation.

However, India continues on the downward trend of new COVID cases. A total of 1,761 fresh COVID cases were recorded nationwide on Sunday which is the lowest in around 688 days. Following a continuous downward trend, India's active caseload has also declined to 26,240, constituting 0.06 per cent of total positive cases.

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay